Valuation Proteomics International Laboratories Ltd
Stocks
PIQ
AU000000PIQ0
Biotechnology & Medical Research
|
Market Closed -
Australian S.E.
23:33:14 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.1200 AUD | 0.00% |
|
-11.11% | -81.68% |
Company Valuation: Proteomics International Laboratories Ltd
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 97.32 | 98.31 | 104 | 115.2 | 53.14 | 19 |
| Change | - | 1.02% | 5.83% | 10.71% | -53.86% | -64.26% |
| Enterprise Value (EV) 1 | 91.78 | 96.19 | 98.08 | 108.9 | 42.39 | 15.83 |
| Change | - | 4.81% | 1.96% | 10.99% | -61.06% | -62.66% |
| P/E | -32.9x | -19.7x | -16.2x | -17.4x | -5.38x | -1.8x |
| PBR | 12.8x | 29x | 12.4x | 12.2x | 4.04x | 3.27x |
| PEG | - | -0.3x | -1.3x | 3.89x | -0.3x | -0.33x |
| Capitalization / Revenue | 35.6x | 28.7x | 32.7x | 35.2x | 16x | 5.64x |
| EV / Revenue | 33.5x | 28x | 30.8x | 33.2x | 12.8x | 4.7x |
| EV / EBITDA | -33.1x | -20.8x | -16.8x | -17.8x | -5.44x | -1.95x |
| EV / EBIT | -29.8x | -19.3x | -15.4x | -16.2x | -5.13x | -1.8x |
| EV / FCF | -72.6x | -52.3x | -19.5x | -30.1x | -12.8x | -2.69x |
| FCF Yield | -1.38% | -1.91% | -5.12% | -3.32% | -7.8% | -37.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0281 | -0.0471 | -0.053 | -0.0507 | -0.0604 | -0.0638 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2.736 | 3.43 | 3.181 | 3.276 | 3.312 | 3.37 |
| EBITDA 1 | -2.774 | -4.624 | -5.836 | -6.114 | -7.791 | -8.132 |
| EBIT 1 | -3.083 | -4.977 | -6.366 | -6.741 | -8.267 | -8.795 |
| Net income 1 | -2.86 | -4.973 | -6.177 | -6.376 | -8.115 | -8.56 |
| Net Debt 1 | -5.536 | -2.112 | -5.963 | -6.324 | -10.76 | -3.169 |
| Reference price 2 | 0.9250 | 0.9300 | 0.8600 | 0.8800 | 0.3250 | 0.1150 |
| Nbr of stocks (in thousands) | 105,206 | 105,706 | 120,979 | 130,893 | 163,521 | 165,184 |
| Announcement Date | 8/30/21 | 8/30/22 | 8/21/23 | 8/22/24 | 8/26/25 | 8/31/26 |
1AUD in Million2AUD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 13.86M | |
| 21.73x | 7.77x | 15.6x | 1.37% | 74.69B | |
| 30.56x | 8.79x | 27.4x | 0.04% | 58.81B | |
| 33.6x | 6.04x | 18.08x | 0.96% | 48.45B | |
| -20.7x | 214.73x | -22.18x | -.--% | 42.84B | |
| 33.49x | 3.25x | 14.04x | -.--% | 42.79B | |
| 48.17x | 5.48x | 30.1x | -.--% | 41.25B | |
| 27.6x | 7.84x | 20.39x | 0.41% | 31.13B | |
| 35.01x | 7.5x | 19.48x | -.--% | 30.28B | |
| -14.91x | 5.52x | -6.94x | -.--% | 24.05B | |
| Average | 21.62x | 29.66x | 12.89x | 0.31% | 39.43B | |
| Weighted average by Cap. | 23.19x | 29.31x | 14.21x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PIQ Stock
- Valuation Proteomics International Laboratories Ltd
Select your edition
All financial news and data tailored to specific country editions
